Aqueous humor nitric oxide levels differ in patients with different types of glaucoma

被引:22
作者
Chang, CJ [1 ]
Chiang, CH [1 ]
Chow, JCK [1 ]
Lu, DW [1 ]
机构
[1] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan
关键词
D O I
10.1089/jop.2000.16.399
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Nitric oxide (NO) has effects on the regulation of aqueous humor dynamics, but the exact mechanism is not yet established. To investigate the possible roles of NO in glaucoma, we determined NO levels in aqueous humor and plasma in glaucoma patients and a control group, cataract patients. The study is an open trial with purposed sampling. One hundred fifty-two patients, including 87 glaucoma patients and 65 cataract patients from two medical centers, were recruited. NO levels in the samples were measured by a chemiluminescence assay. We found that, although the mean aqueous humor NO level (mean +/- SEM) was higher in the glaucoma patients than in the cataract patients (39.7 +/- 1.5 muM VS. 35.5 +/- 1.3 muM, p < 0.05), NO levels varied significantly in different types of glaucoma. The juvenile glaucoma patients had the lowest mean NO level (8.4 +/- 0.9 <mu>M), while the acute angle-closure glaucoma and neovascular glaucoma patients had the highest mean NO levels (64.8 +/- 7.6 muM, 67.3 +/- 8.2 muM) In comparison, the mean plasma NO level in the glaucoma patients was not statistically different from that in the cataract patients (14.1 +/- 1.2 muM VS. 13.9 +/- 1.1 muM, p = 0.91). Our data may provide information for applying NO-mimicking nitrovasodilators in the treatment of glaucoma.
引用
收藏
页码:399 / 406
页数:8
相关论文
共 24 条
[1]  
Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36
[2]  
BeharCohen FF, 1996, INVEST OPHTH VIS SCI, V37, P1711
[3]   Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population - The Rotterdam study [J].
Dielemans, I ;
deJong, PTVM ;
Stolk, R ;
Vingerling, JR ;
Grobbee, DE ;
Hofman, A .
OPHTHALMOLOGY, 1996, 103 (08) :1271-1275
[4]  
FLUGELKOCH C, 1994, INVEST OPHTH VIS SCI, V35, P4268
[5]   Glaucoma and nitric oxide [J].
Grierson, I .
LANCET, 1996, 347 (9018) :1781-1782
[6]  
KAUFMAN PL, 1992, APPL PHARM GLAUCOMAS, P4
[7]  
KLEM M, 1997, J BIOL CHEM, V272, P9922
[8]  
KOSTKA P, 1995, ANAL CHEM, V67, pR411
[9]   A REDOX-BASED MECHANISM FOR THE NEUROPROTECTIVE AND NEURODESTRUCTIVE EFFECTS OF NITRIC-OXIDE AND RELATED NITROSO-COMPOUNDS [J].
LIPTON, SA ;
CHOI, YB ;
PAN, ZH ;
LEI, SZZ ;
CHEN, HSV ;
SUCHER, NJ ;
LOSCALZO, J ;
SINGEL, DJ ;
STAMLER, JS .
NATURE, 1993, 364 (6438) :626-632
[10]   IMPROVEMENT OF RETINAL FUNCTIONS AFTER ISCHEMIA WITH L-ARGININE AND ITS DERIVATIVES [J].
LIU, SXL ;
CHIOU, GCY ;
VARMA, RS .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1995, 11 (03) :261-265